• Learning Objective 1: To educate the audience regarding the current status of adoptive cell therapy drug development.
  • Learning Objective 2: To educate the audience regarding the fundamental principles of CAR T cell therapeutics.
  • Learning Objective 3: Provide current data regarding activity of CAR T cells against children's cancers.
Session date: 
12/08/2022 - 12:00pm to 1:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Crystal Mackall, MD